International Drug Development Institute (Belgium)
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
-
- Statistical Methods in Clinical Trials 71
- Advanced Causal Inference Techniques 25
- Oncology 102
- Colorectal Cancer Treatments and Studies 41
- HER2/EGFR in Cancer Research 22
- Cancer Treatment and Pharmacology 20
- Top scholars
- Marc BuyseTomasz BurzykowskiGeert MolenberghsMartine PiccartAimery de GramontChristos SotiriouMauro DelorenziPascal Piedbois
- Journals
- Journal of Clinical Oncology (49 papers)Annals of Oncology (27 papers)Statistics in Medicine (12 papers)Cancer Research (10 papers)JNCI Journal of the National Cancer Institute (9 papers)
- Partner nations
- BelgiumUnited StatesFrance
In The Last Decade
International Drug Development Institute (Belgium)
269 papers receiving 12.9k citations
Peers
Comparison fields: 5 of 188
- Oncology 5.9k
- Cancer Research 3.1k
- Statistics and Probability 1.9k
- Hepatology 1.0k
- Reproductive Medicine 571
Countries citing scholars working at International Drug Development Institute (Belgium)
This map shows the geographic impact of research produced by authors working at International Drug Development Institute (Belgium). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at International Drug Development Institute (Belgium) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites International Drug Development Institute (Belgium) more than expected).
Fields of papers published by authors at International Drug Development Institute (Belgium)
This network shows the impact of papers affiliated with International Drug Development Institute (Belgium) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with International Drug Development Institute (Belgium) at the time of their publication.
About International Drug Development Institute (Belgium)
In recent decades, authors affiliated with International Drug Development Institute (Belgium) have published 332 papers, which have received a total of 17.0k indexed citations . Scholars at this organization have produced 77 papers in Statistics and Probability, 102 papers in Oncology, 50 papers in Cancer Research, 3 papers in Family Practice and 13 papers in Statistics, Probability and Uncertainty on the topics of Statistical Methods in Clinical Trials (71 papers), Colorectal Cancer Treatments and Studies (41 papers), Health Systems, Economic Evaluations, Quality of Life (36 papers), Cancer Genomics and Diagnostics (26 papers), Advanced Causal Inference Techniques (25 papers), HER2/EGFR in Cancer Research (22 papers), Breast Cancer Treatment Studies (20 papers) and Cancer Treatment and Pharmacology (20 papers). Their work is cited by papers focused on Oncology (5.9k citations), Cancer Research (3.1k citations), Statistics and Probability (1.9k citations), Hepatology (1.0k citations) and Reproductive Medicine (571 citations). Authors at International Drug Development Institute (Belgium) collaborate with scholars in Belgium, United States and France and have published in prestigious journals including Journal of Clinical Oncology, Annals of Oncology, Statistics in Medicine, Cancer Research and JNCI Journal of the National Cancer Institute. Some of International Drug Development Institute (Belgium)'s most productive authors include Marc Buyse, Tomasz Burzykowski, Geert Molenberghs, Martine Piccart, Aimery de Gramont, Christos Sotiriou, Mauro Delorenzi, Pascal Piedbois, Emmanuel Quinaux and Christine Desmedt.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.